)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Revvity
Revvity (RVTY) investor relations material
Revvity Barclays 28th Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Barclays 28th Annual Global Healthcare Conference summary10 Mar, 2026
Signals platform and AI integration
Signals platform includes ChemDraw, Signals One, and Spotfire, serving as core tools for research scientists to design, store, and analyze molecular data.
AI is viewed as an accelerator, not a disruptor, enhancing the capabilities and efficiency of the Signals suite.
New launches—BioDesign, LabGistics, and Xynthetica—expand the platform to large molecule design, lab logistics, and operationalizing machine learning models.
Xynthetica acts as an iOS-like system, enabling access to both proprietary and public machine learning models for research, with a consumption-based revenue model.
Productization of Xynthetica with partners like Lilly is expected in the second half of the year, with ongoing discussions for broader adoption.
Financial outlook and growth strategy
Signals business is projected to grow at 9%-11% in the long-range plan, with actual performance trending in the low- to mid-teens APV.
New launches are expected to drive growth, with a goal to double the Signals business within four to five years.
Signals revenue model is shifting from seat-based subscriptions to a consumption-based approach, especially with Xynthetica.
Margin expansion is anticipated, with cost-cutting and operational efficiencies expected to benefit the second half of the year and into 2027.
Guidance remains conservative, factoring in potential policy headwinds, especially from China, and assumes stable but not robust pharma demand.
Competitive landscape and market dynamics
BioLegend has gained market share in a depressed reagents market, focusing on service, quality, and scientific partnership.
Flow cytometry reagents represent about 30% of the total reagents business, with other assays like AlphaLISA and HTRF contributing to growth.
Long-term reagent programs provide business stability, with growth tied to ongoing pharma and biotech discovery projects.
The funding environment for biotech is stabilizing, with early signs of renewed investment in innovation and preclinical research.
M&A activity and competitive shifts are ongoing, but differentiation is driven by scientific innovation and customer collaboration.
Explain Xynthetica's consumption revenue model
Bridge the 1,000 bps Q1 to Q4 margin expansion
BioLegend strategy against flow market M&A
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Revvity earnings date
Q1 202627 Apr, 2026
Revvity
Next Revvity earnings date
Q1 202627 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Revvity Inc., formerly known as PerkinElmer Inc., is an American life sciences and diagnostics company. It offers a wide range of health science solutions, technologies, expertise, and services, aiming to cover the complete workflow from discovery to development, and diagnosis to cure. The company primarily serves the pharmaceutical and biotechnology industries, with a special focus on cell therapy and gene therapy developments. Revvity operates in two main segments: diagnostics, and life sciences research and laboratory services markets. By providing products, services, and solutions globally, Revvity supports the diagnostics, life sciences, and applied services markets. The company is committed to driving innovation in healthcare, emphasizing the development of technologies and solutions across disease pathways. Revvity Inc. is headquartered in Waltham, Massachusetts, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage